Literature DB >> 25252607

Improved statistical analysis of pre- and post-treatment patient-reported outcome measures (PROMs): the applicability of piecewise linear regression splines.

M E Greene1, O Rolfson, G Garellick, M Gordon, S Nemes.   

Abstract

PURPOSE: Patient-reported health-related quality-of-life (HRQoL) measures such as the EuroQol 5 dimension (EQ-5D) index are commonplace when assessing healthcare providers or efficiency of medical techniques. HRQoL measures are generally bounded, and the magnitude of possible improvement depends on the pre-treatment HRQoL value. This paper aimed to assess and illustrated the possibility of modelling the relationship between pre- and post-treatment HRQoL measures with piecewise linear splines.
METHODS: The method was illustrated using a longitudinal dataset of 36,625 patients with one EQ-5D index before and one a year after total hip arthroplasty. We considered four models: intercept only model, single line regression, and segmented regression with 1 and 2 change points. The post-operative EQ-5D index served as the outcome, while the preoperative EQ-5D index was the predictor.
RESULTS: We found that a two-line regression best described the data with the lines meeting at 0.159 on the preoperative EQ-5D index scale. In the low preoperative group (with an initial preoperative index from -0.594 to 0.159), the predicted post-operative scores ranged from 0.368 to 0.765, with post-operative scores increasing 0.528 points for each unit in the preoperative score. In the high preoperative group (initial range from 0.159 to 1), the predicted post-operative scores ranged from 0.765 to 0.855, increasing 0.106 points for each unit in the preoperative score.
CONCLUSIONS: Piecewise linear regression is a straightforward approach to analyse baseline and follow-up HRQoL measures such as the EQ-5D index. It can provide a reasonable approximation of the shape of the underlying relationship where the threshold and slopes prove informative and meaningful.

Entities:  

Mesh:

Year:  2014        PMID: 25252607     DOI: 10.1007/s11136-014-0808-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

Review 2.  Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Authors:  A J Vickers; D G Altman
Journal:  BMJ       Date:  2001-11-10

Review 3.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

Review 4.  Use of patient-reported outcomes in the context of different levels of data.

Authors:  Ola Rolfson; Alastair Rothwell; Art Sedrakyan; Kate Eresian Chenok; Eric Bohm; Kevin J Bozic; Göran Garellick
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

Review 5.  A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods.

Authors:  Gunnar Steineck; Hayley Hunt; Jan Adolfsson
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

6.  Estimating regression models with unknown break-points.

Authors:  Vito M R Muggeo
Journal:  Stat Med       Date:  2003-10-15       Impact factor: 2.373

7.  Use of two-segmented logistic regression to estimate change-points in epidemiologic studies.

Authors:  R Pastor; E Guallar
Journal:  Am J Epidemiol       Date:  1998-10-01       Impact factor: 4.897

8.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

9.  On the uses of routine patient-reported health outcome data.

Authors:  Peter C Smith; Andrew D Street
Journal:  Health Econ       Date:  2012-01-11       Impact factor: 3.046

10.  Patient reported outcome measures could help transform healthcare.

Authors:  Nick Black
Journal:  BMJ       Date:  2013-01-28
View more
  7 in total

1.  Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.

Authors:  Xinhui Chen; Jose R Castillo-Mancilla; Sharon M Seifert; Kevin B McAllister; Jia-Hua Zheng; Lane R Bushman; Samantha MaWhinney; Peter L Anderson
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Can patient-reported outcomes predict re-operations after total hip replacement?

Authors:  Ted Eneqvist; Szilárd Nemes; Erik Bülow; Maziar Mohaddes; Ola Rolfson
Journal:  Int Orthop       Date:  2018-01-03       Impact factor: 3.075

3.  Assessing heart rate variability biofeedback as an adjunct to college recovery housing programs.

Authors:  David Eddie; Fiona N Conway; Nour Alayan; Jennifer Buckman; Marsha E Bates
Journal:  J Subst Abuse Treat       Date:  2018-06-28

4.  Is the use of antidepressants associated with patient-reported outcomes following total hip replacement surgery?

Authors:  Meridith E Greene; Ola Rolfson; Max Gordon; Kristina Annerbrink; Henrik Malchau; Göran Garellick
Journal:  Acta Orthop       Date:  2016-08-02       Impact factor: 3.717

5.  Is Preoperative Patient-Reported Health Status Associated with Mortality after Total Hip Replacement?

Authors:  Peter Cnudde; Szilard Nemes; Maziar Mohaddes; John Timperley; Göran Garellick; Kristina Burström; Ola Rolfson
Journal:  Int J Environ Res Public Health       Date:  2017-08-10       Impact factor: 3.390

6.  Properties of the EQ-5D-5L when prospective longitudinal data from 28,902 total hip arthroplasty procedures are applied to different European EQ-5D-5L value sets.

Authors:  Anders Joelson; Peter Wildeman; Freyr Gauti Sigmundsson; Ola Rolfson; Jan Karlsson
Journal:  Lancet Reg Health Eur       Date:  2021-07-14

7.  Linking Swedish health data registers to establish a research database and a shared decision-making tool in hip replacement.

Authors:  Peter Cnudde; Ola Rolfson; Szilard Nemes; Johan Kärrholm; Clas Rehnberg; Cecilia Rogmark; John Timperley; Göran Garellick
Journal:  BMC Musculoskelet Disord       Date:  2016-10-04       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.